Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals With Nonalcoholic Fatty Liver Disease Kathleen E. Corey, Naga Chalasani Clinical Gastroenterology and Hepatology Volume 12, Issue 7, Pages 1077-1084 (July 2014) DOI: 10.1016/j.cgh.2013.08.014 Copyright © 2014 AGA Institute Terms and Conditions
Figure 1 Evaluation and management of cardiovascular risk in NAFLD. FH, family history; HbA1C, glycosylated hemoglobin. Adapted from the NCEP program Adult Treatment Panel III guidelines.12 Clinical Gastroenterology and Hepatology 2014 12, 1077-1084DOI: (10.1016/j.cgh.2013.08.014) Copyright © 2014 AGA Institute Terms and Conditions